Healthcare Triangle Q2 Revenue Jumps 158% but Misses Estimates
HCTI sits 38% above its 52-week low of $1 on light trading volume (0.1× avg).
Summary
Healthcare Triangle reported Q2 revenue of $9.19 million, a 158% year-over-year increase driven by the Teyame and Datono acquisitions, but fell short of the $10.35 million consensus estimate. Gross profit surged 322% with gross margin expanding to 22.5%, helped by the AI-powered customer engagement segment which contributed $6.31 million, or 69% of revenue. The company did not provide forward guidance. This follows a series of highly dilutive financing moves and shareholder-approved dilution, with the stock trading near $1.24. The revenue miss relative to the single analyst estimate is a modest negative, but the strong growth and margin expansion may limit downside.
At the time of this announcement, HCTI was trading at $1.38 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $1.00 to $244.80. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.